Shaala Lamiaa A, Youssef Diaa T A, Badr Jihan M, Harakeh Steve M
Natural Products Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Suez Canal University Hospital, Suez Canal University, Ismailia 41522, Egypt.
Molecules. 2016 Aug 24;21(9):1116. doi: 10.3390/molecules21091116.
As a part of our ongoing effort to allocate marine microbial bioactive leads, a tunicate-derived actinomycete, Streptomyces sp. Did-27, was investigated. Three new 2(1H)-pyrazinones derivatives, (S)-6-(sec-butyl)-3-isopropylpyrazin-2(1H)-one (1), (S)-3-(sec-butyl)-6-isopropylpyrazin-2(1H)-one (2) and (S)-6-(sec-butyl)-3-isobutylpyrazin-2(1H)-one (3), together with the known (1H)-pyrazinones analogues deoxymutaaspergillic acid (4), 3,6-diisobutyl-2(1H)-pyrazinone (5) and 3,6-di-sec-butyl-2(1H)-pyrazinone (6), and the diketopiperazine alkaloids cyclo(6-OH-d-Pro-l-Phe) (7), bacillusamide B (8), cyclo(l-Pro-l-Leu) and cyclo(l-Pro-l-Ile) (10) were isolated from this strain. The structures of the compounds were determined by study of their one- and two-dimensional NMR spectra as well as high-resolution mass spectral determinations. Compound 4 was reported previously as a synthetic product, while compound 6 was reported as 2-hydroxy-3,6-di-sec-butylpyrazine. Herein, we report the complete NMR data for compounds 4 and 6. The compounds were evaluated for their cytotoxic activities against three cell lines. Compound 5 showed potent and selective activity against HCT-116 cell line with IC50 of 1.5 μg/mL, while 1-10 showed variable cytotoxic activities against these cancer cell lines. These results provide further understanding about the chemistry and bioactivities of the alkylated 2(1H)-pyrazinone derivatives.
作为我们持续开展的海洋微生物生物活性先导化合物筛选工作的一部分,对一种源自被囊动物的放线菌链霉菌属菌株Did-27进行了研究。从该菌株中分离出了三种新的2(1H)-吡嗪酮衍生物,(S)-6-(仲丁基)-3-异丙基吡嗪-2(1H)-酮(1)、(S)-3-(仲丁基)-6-异丙基吡嗪-2(1H)-酮(2)和(S)-6-(仲丁基)-3-异丁基吡嗪-2(1H)-酮(3),以及已知的(1H)-吡嗪酮类似物脱氧变曲霉菌酸(4)、3,6-二异丁基-2(1H)-吡嗪酮(5)和3,6-二仲丁基-2(1H)-吡嗪酮(6),还有二酮哌嗪生物碱环(6-OH-d-脯氨酸-l-苯丙氨酸)(7)、芽孢杆菌酰胺B(8)、环(l-脯氨酸-l-亮氨酸)和环(l-脯氨酸-l-异亮氨酸)(10)。通过对其一维和二维核磁共振谱以及高分辨率质谱测定的研究确定了这些化合物的结构。化合物4之前被报道为合成产物,而化合物6之前被报道为2-羟基-3,6-二仲丁基吡嗪。在此,我们报道化合物4和6的完整核磁共振数据。对这些化合物针对三种细胞系的细胞毒性活性进行了评估。化合物5对HCT-116细胞系表现出强效且选择性的活性,IC50为1.5μg/mL,而化合物1 - 10对这些癌细胞系表现出不同程度的细胞毒性活性。这些结果为烷基化2(1H)-吡嗪酮衍生物的化学性质和生物活性提供了进一步的认识。